Anil Vasudevan
Overview
Explore the profile of Anil Vasudevan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
621
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yarawsky A, Ronau J, Thibaudeau T, Ehlinger A, Chhor G, Hyman S, et al.
Eur Biophys J
. 2025 Feb;
PMID: 39961810
Targeted protein degradation (TPD) has garnered appreciable interest in drug discovery due to its unique mechanism of action - degradation of a target in an event-driven manner, instead of traditional...
2.
Basu A, Zhang C, Rouhimoghadam M, Vasudevan A, Reitsma J, Zhang X
J Am Chem Soc
. 2025 Feb;
147(7):6108-6115.
PMID: 39913332
Targeted protein degradation (TPD) is a pharmacological strategy that eliminates specific proteins from cells by harnessing cellular proteolytic degradation machinery. In proteasome-dependent TPD, expanding the repertoire of E3 ligases compatible...
3.
Alhasan K, Raina R, Boyer O, Koh J, Bonilla-Felix M, Sethi S, et al.
Pediatr Nephrol
. 2024 Dec;
PMID: 39733391
The coronavirus disease 2019 (COVID-19) pandemic, instigated by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has profoundly impacted healthcare infrastructures around the globe. While children are usually asymptomatic or...
4.
Basu A, Zhang C, Rouhimoghadam M, Vasudevan A, Reitsma J, Zhang X
bioRxiv
. 2024 Dec;
PMID: 39677626
Targeted protein degradation (TPD) is a pharmacological strategy that eliminates specific proteins from cells by harnessing cellular proteolytic degradation machinery. In proteasome-dependent TPD, expanding the repertoire of E3 ligases compatible...
5.
Garg M, V L, Vasudevan A
J Pediatr Intensive Care
. 2024 Dec;
13(3):276-281.
PMID: 39629150
Peritoneal dialysis (PD) is a simple and preferred modality of dialysis for children with acute kidney injury (AKI) in resource poor countries. The aim of the study is to evaluate...
6.
Reddy S, Ghante A, Vankalakunti M, Vasudevan A
Clin Exp Pediatr
. 2024 Nov;
PMID: 39608366
Background: In children, C3 glomerulopathy (C3G) is a heterogeneous disease characterized by diverse clinicopathological profiles and kidney outcomes. However, diagnostic work-up in resource-limited settings is challenging because of the unavailability...
7.
Lalitha A, Vasudevan A, Moorthy M, Ramaswamy G
Indian J Crit Care Med
. 2024 Oct;
28(9):879-886.
PMID: 39360202
Background: Septic shock is associated with high mortality and there is significant heterogeneity in the host response. The aim of this study was to understand the genome-wide expression transcriptomic signatures...
8.
Deepthi B, Krishnasamy S, Krishnamurthy S, Khandelwal P, Sinha A, Hari P, et al.
Pediatr Nephrol
. 2024 Aug;
40(2):407-416.
PMID: 39150521
Background: Limited data, primarily from small case series, exist regarding the clinical profile, genetic variants, and outcomes of WDR72-associated distal renal tubular acidosis (WDR72-dRTA). Methods: Our study enrolled children diagnosed...
9.
Lynch 4th T, Marin V, McClure R, Phipps C, Ronau J, Rouhimoghadam M, et al.
ACS Chem Biol
. 2024 Jul;
19(7):1604-1615.
PMID: 38980123
Targeted protein degradation (TPD) is a therapeutic approach that leverages the cell's natural machinery to degrade targets instead of inhibiting them. This is accomplished by using mono- or bifunctional small...
10.
Iyengar A, Collins S, Ashok J, Vasudevan A
Indian J Nephrol
. 2023 Oct;
33(4):264-269.
PMID: 37781562
Introduction: There is a need to explore less laborious point-of-care assessment tools to diagnose protein energy wasting (PEW) in children with chronic kidney disease (CKD). This cross-sectional study was undertaken...